Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
 Your new post is loading...
Your new post is loading...
Scoop.it!
A daily dose of Nestlé’s Bifidobacterium lactis NCC2818 probiotic strain may help manage allergic responses during pollen season, says a new study from the Nestlé Research Center. 
No comment yet.
Sign up to comment
Scoop.it!
Japanese red cedar is a huge tree that can hit 70 meters tall, and it manages to get up the noses of almost half the people in Japan–around 45% of the population is allergic to its pollen. Immunomic Therapeutics is developing a DNA plasmid-based allergy vax for this allergy, code-named JRC-LAMP-vax, and has been cleared by the U.S. FDA to begin a Phase I clinical trial in Atlanta in June 2012. The immunotherapy is likely to have a lucrative market in the U.S. as well as in Japan, as North American mountain cedar pollen is similar enough that the shot will work against both targets. In clinical studies of other DNA LAMP vaccines, the shots “re-educate” the immune system, desensitizing people against the allergen. Read more: Red cedar allergy DNA vax hits the clinic – FierceVaccines http://www.fiercevaccines.com/story/red-cedar-allergy-dna-vax-hits-clinic/2012-05-09#ixzz26q54VxxF
|
Scoop.it!
Allergy/Immunology Medical Article: High-dose sublingual immunotherapy with single-dose aqueous grass pollen extract in children is effective and safe: A double-blind, placebo-controlled study (Conjunctivitus + grass reared kids Allergy- High-dose... Wahn U et al. – This study confirmed that this sublingual immunotherapy (SLIT) preparation significantly reduced symptoms and medication use in children with grass pollen–allergic rhinoconjunctivitis. The preparation showed significant effects on allergen–specific antibodies, was well tolerated, and appeared to be a valid therapeutic option in children allergic to grass pollen.
|
Very interesting paper. I think that whatever nutritional natural complement is always better than any new pill to take.
Link to the European Journal of Clinical Nutrition original publication:
www.nature.com/ejcn/journal/vaop/ncurrent/abs/ejcn2012197a.html
Original ArticleEuropean Journal of Clinical Nutrition advance online publication 9 January 2013; doi: 10.1038/ejcn.2012.197
Immune-modulatory effect of probiotic Bifidobacterium lactis NCC2818 in individuals suffering from seasonal allergic rhinitis to grass pollen: an exploratory, randomized, placebo-controlled clinical trialA Singh1, F Hacini-Rachinel1,4, M L Gosoniu2, T Bourdeau1, S Holvoet1, R Doucet-Ladeveze1, M Beaumont3, A Mercenier1 and S Nutten1